Myovant Sciences' new campaign brings together men with prostate cancer to share stories of diagnoses, treatment, stigma and the importance of support.

September 26, 2022 02:10 PM EDTUpdated 03:44 PM

Marketing

Myovant launches new patient storytelling platform, debuts with video series on prostate cancer

Beth Snyder Bulik

Senior Editor

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Myovant launches new patient storytelling platform, debuts with video series on prostate cancer

Beth Snyder Bulik

Senior Editor

Sign up to read this article for free.

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Deputy FDA chief mulls shaking up PDUFA reauthorization structure

Lower attendance at cell and gene therapy conference mirrors challenged industry

FDA poses efficacy, safety questions over four cancer drugs ahead of two-day adcomm

Updated: Novo Nordisk CEO to step down amid stock decline, timeline for successor unknown

HHS can require approval for drugmakers to apply 340B rebate models, court rules

Novo Nordisk’s global obesity leader is moving on; Flagship biotech gets CEO from Scholar Rock

My­ovant launch­es new pa­tient sto­ry­telling plat­form, de­buts with video se­ries on prostate can­cer

Senior Editor

Sign up to read this article for free.

more like this

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Myovant launches new patient storytelling platform, debuts with video series on prostate cancer